Total Valuation
INBIOGEN CO., Ltd. has a market cap or net worth of ₩53.12B. The enterprise value is ―.
Market Cap₩53.12B
Enterprise Value―
Share Statistics
INBIOGEN CO., Ltd. has 10,044,217 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding10,044,217
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
INBIOGEN CO., Ltd.’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is -2.73%.
Return on Equity (ROE)0.04
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)-2.73%
Return on Capital Employed (ROCE)-0.03
Revenue Per Employee153.58M
Profits Per Employee-34.60M
Employee Count41
Asset Turnover0.04
Inventory Turnover229.57
Valuation Ratios
The current PE Ratio of INBIOGEN CO., Ltd. is ―. INBIOGEN CO., Ltd.’s PEG ratio is -0.28.
PE Ratio―
PS Ratio16.73
PB Ratio0.67
Price to Fair Value0.67
Price to FCF-18.83
Price to Operating Cash Flow-12.14
PEG Ratio-0.28
Income Statement
In the last 12 months, INBIOGEN CO., Ltd. had revenue of 6.30B and earned 5.82B in profits. Earnings per share was 579.79.
Revenue6.30B
Gross Profit-574.39M
Operating Income-4.33B
Pretax Income-1.42B
Net Income5.82B
EBITDA-3.97B
Earnings Per Share (EPS)579.79
Cash Flow
In the last 12 months, operating cash flow was -4.29B and capital expenditures -10.10M, giving a free cash flow of -4.30B billion.
Operating Cash Flow-4.29B
Free Cash Flow-4.30B
Free Cash Flow per Share-428.44
Dividends & Yields
INBIOGEN CO., Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.27
52-Week Price Change-47.75%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)5.86K
Important Dates
INBIOGEN CO., Ltd. upcoming earnings date is Aug 17, 2026, TBA (Confirmed).
Last Earnings DateMay 15, 2026
Next Earnings DateAug 17, 2026
Ex-Dividend Date―
Financial Position
INBIOGEN CO., Ltd. as a current ratio of 2.86, with Debt / Equity ratio of 2.87%
Current Ratio2.86
Quick Ratio2.84
Debt to Market Cap<0.01
Net Debt to EBITDA-0.07
Interest Coverage Ratio-55.23
Taxes
In the past 12 months, INBIOGEN CO., Ltd. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
INBIOGEN CO., Ltd. EV to EBITDA ratio is -26.61, with an EV/FCF ratio of -18.87.
EV to Sales16.77
EV to EBITDA-26.61
EV to Free Cash Flow-18.87
EV to Operating Cash Flow-19.02
Balance Sheet
INBIOGEN CO., Ltd. has ₩3.53B in cash and marketable securities with ₩4.11B in debt, giving a net cash position of -₩575.79M billion.
Cash & Marketable Securities₩3.53B
Total Debt₩4.11B
Net Cash-₩575.79M
Net Cash Per Share-₩57.33
Tangible Book Value Per Share₩15.70K
Margins
Gross margin is -8.90%, with operating margin of -68.81%, and net profit margin of 92.48%.
Gross Margin-8.90%
Operating Margin-68.81%
Pretax Margin-22.53%
Net Profit Margin92.48%
EBITDA Margin-63.04%
EBIT Margin-68.81%
Analyst Forecast
The average price target for INBIOGEN CO., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-25.55%
EPS Growth Forecast-143.84%